SNUG01 showed favorable safety and signs of early clinical efficacy in a recently completed investigator-initiated trial in China, the firm said.

Q2 2025 Management View Chaim Lebovits, President and CEO, reaffirmed that "our top priority is advancing NurOwn into our planned Phase IIIb clinical trial." The ENDURANCE trial is designed to confirm ...

Athira Pharma (ATHA) presented results from its Phase 1 clinical trial of ATH-1105 in healthy volunteers at the ALS Nexus 2025 conference in ...

Athira Pharma, Inc. (NASDAQ: ATHA), a clinical stage biopharmaceutical company focused on developing small molecules to ...

It may be time to rethink certain genetic mutations associated with two devastating neurodegenerative disorders—amyotrophic ...

The order applies to the entirety of new and, possibly, ongoing research grant dollars that go to universities and academic medical centers.

On Sunday, October 5, the San Diego community will come together for the 24th Annual Walk to Defeat ALS, a fundraising event ...

After the success of last year’s benefit, The Young and the Restless’ Kate Linder is partnering with the ALS Network for another fundraiser to benefit ALS Research & Care on Sunday, August 17 ...

What would you do if you found out you were a carrier for a debilitating disease like ALS? Author Mindy Uhrlaub discovered that about herself and decided to become an advocate for people suffering ...

Hundreds of documents show how researchers failed to notify officials in California about a test of technology to block the sun’s rays — while they planned ...

In partnership with ALS United Rocky Mountain, Nix sold "Bolieve" T-shirts and raised $10,000 for the nonprofit. "All of it goes to (ALS) research and finding ways to get on top of it. I think it ...